Norris Medicines Ltd Faces Intensified Selling Pressure Amid Consecutive Losses
Norris Medicines Ltd is experiencing notable selling pressure, continuing a trend of losses. While the stock has shown some gains over the past week and year-to-date, its recent performance has lagged behind the Sensex, raising concerns about volatility and market sentiment challenges.
Norris Medicines Ltd is currently facing significant selling pressure, with the stock showing only sellers today. This trend marks a continuation of consecutive days of losses, highlighting a challenging period for the microcap pharmaceutical company. In terms of performance, Norris Medicines has underperformed relative to the Sensex, with a decline of 0.05% today compared to the Sensex's gain of 0.93%. Over the past week, the stock has gained 0.92%, but this is notably lower than the Sensex's increase of 4.65%. The one-month performance reveals a more concerning trend, with Norris Medicines down 6.87%, while the Sensex has risen by 4.25%.
Despite a strong year-to-date performance of 7.78% against the Sensex's decline of 0.67%, the stock's recent trajectory raises questions. The price summary indicates that Norris Medicines is currently higher than its 5-day and 200-day moving averages but lower than its 20-day, 50-day, and 100-day moving averages. This mixed performance could suggest underlying volatility and market sentiment challenges contributing to the selling pressure.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
